No Prescription |
 |
 | ||
|
Dilzem LA Cartia XT |
|
| ||
No Prescription » Prescription Drugs 6 » Dilzem LA Cartia XT Diltiazem is used to treat high blood pressure and to control chest pain (angina). Diltiazem is in a class of medications called calcium-channel blockers. It works by relaxing the blood vessels so the heart does not have to pump as hard. It also increases the supply of blood and oxygen to the heart.Diltiazem comes as a tablet and an extended- or dual-release (long-acting) capsule to take by mouth. The tablet is usually taken three or four times a day with or without food. The capsule is usually taken one or two times a day. The extended-release capsule (Cardizem SR Dilacor XR Diltia XT) should be taken on an empty stomach at least 1 hour before or 2 hours after a meal. The extended-release capsule (Tiazac) may be taken with or without food. The dual-release capsule (Cardizem CD) may be taken with food.Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take diltiazem exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Swallow the capsules whole; do not split chew or crush them.Your doctor will probably start you on a low dose of diltiazem and gradually increase your dose.If taken regularly diltiazem controls chest pain but it does not stop chest pain once it starts. Your doctor may give you a different medication to take when you have chest pain.Diltiazem controls high blood pressure and chest pain (angina) but does not cure them. It may take up to 2 weeks before you feel the full benefit of diltiazem. Continue to take diltiazem even if you feel well. Do not stop taking diltiazem without talking to your doctor.Diltiazem is also used sometimes to treat Raynaud's syndrome. Buy Dilzem LA Cartia XT and other Prescription Drugs 6 products online at Medstore. Buy Online at Medstore - Click Here!
About Dilzem LA Cartia XT: Product Type: Prescription Drugs 6 Dilzem LA ( Cartia XT Tiazac Cardizem Diltia Generic Diltiazem ) Dilzem LA (Cartia XT Tiazac Cardizem Diltia Generic Diltiazem) Cartia XT Tiazac Cardizem Diltia Generic Diltiazem 180mg 30 tabs 240mg Cartia XT Tiazac Cardizem Diltia Generic Diltiazem Dilzem LA
View more Prescription Drugs 6 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
